Cargando…
伊立替康二线治疗难治性复发小细胞肺癌的疗效分析
BACKGROUND AND OBJECTIVE: Among malignant tumors, lung cancer has the highest mortality rate. Small cell lung cancer (SCLC) is a kind of malignant lung cancer. Its doubling time is very fast. Patients are prone to drug resistance during treatment, and their condition often deteriorates rapidly after...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143965/ https://www.ncbi.nlm.nih.gov/pubmed/33819966 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.04 |